• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Generation and Comparative Kinetic Analysis of New Glycosynthase Mutants from Streptococcus pyogenes Endoglycosidases for Antibody Glycoengineering.化脓性链球菌内切糖苷酶新型糖基合酶突变体的产生及其在抗体糖基工程中的比较动力学分析
Biochemistry. 2018 Sep 4;57(35):5239-5246. doi: 10.1021/acs.biochem.8b00719. Epub 2018 Aug 22.
2
Glycosynthase Mutants of Endoglycosidase S2 Show Potent Transglycosylation Activity and Remarkably Relaxed Substrate Specificity for Antibody Glycosylation Remodeling.内切糖苷酶S2的糖基合酶突变体表现出强大的转糖基化活性以及对抗体糖基化重塑显著宽松的底物特异性。
J Biol Chem. 2016 Aug 5;291(32):16508-18. doi: 10.1074/jbc.M116.738765. Epub 2016 Jun 10.
3
Site-specific immobilization of endoglycosidases for streamlined chemoenzymatic glycan remodeling of antibodies.用于简化抗体化学酶促聚糖重塑的内切糖苷酶的位点特异性固定化。
Carbohydr Res. 2018 Mar 22;458-459:77-84. doi: 10.1016/j.carres.2018.02.007. Epub 2018 Feb 15.
4
Generation of efficient mutants of endoglycosidase from Streptococcus pyogenes and their application in a novel one-pot transglycosylation reaction for antibody modification.从酿脓链球菌中生成高效内切糖苷酶突变体及其在新型一锅式糖基转移反应中用于抗体修饰的应用。
PLoS One. 2018 Feb 23;13(2):e0193534. doi: 10.1371/journal.pone.0193534. eCollection 2018.
5
Chemoenzymatic glycoengineering of intact IgG antibodies for gain of functions.化学酶学生物糖基化修饰完整 IgG 抗体以获得功能。
J Am Chem Soc. 2012 Jul 25;134(29):12308-18. doi: 10.1021/ja3051266. Epub 2012 Jul 16.
6
One-pot enzymatic glycan remodeling of a therapeutic monoclonal antibody by endoglycosidase S (Endo-S) from Streptococcus pyogenes.通过来自化脓性链球菌的内切糖苷酶 S(Endo-S)对治疗性单克隆抗体进行一锅酶法糖基化修饰。
Bioorg Med Chem. 2018 Apr 1;26(7):1347-1355. doi: 10.1016/j.bmc.2017.07.053. Epub 2017 Jul 29.
7
Development of glycosynthases with broad glycan specificity for the efficient glyco-remodeling of antibodies.发展具有广泛聚糖特异性的糖基合成酶,以有效进行抗体的糖基重塑。
Chem Commun (Camb). 2018 Jun 12;54(48):6161-6164. doi: 10.1039/c8cc03384f.
8
Generation of a Mutant Mucor hiemalis Endoglycosidase That Acts on Core-fucosylated N-Glycans.一种作用于核心岩藻糖基化 N-聚糖的突变型冬生毛霉内切糖苷酶的产生。
J Biol Chem. 2016 Oct 28;291(44):23305-23317. doi: 10.1074/jbc.M116.737395. Epub 2016 Sep 14.
9
Remarkable transglycosylation activity of glycosynthase mutants of endo-D, an endo-β-N-acetylglucosaminidase from Streptococcus pneumoniae. 肺炎链球菌内切-β-N-乙酰氨基葡萄糖苷酶的突变糖基转移酶具有显著的转糖基活性。
J Biol Chem. 2012 Mar 30;287(14):11272-81. doi: 10.1074/jbc.M112.340497. Epub 2012 Feb 8.
10
Endo-F3 Glycosynthase Mutants Enable Chemoenzymatic Synthesis of Core-fucosylated Triantennary Complex Type Glycopeptides and Glycoproteins.内切-F3糖基合酶突变体实现核心岩藻糖基化三天线复合型糖肽和糖蛋白的化学酶法合成。
J Biol Chem. 2016 Apr 22;291(17):9356-70. doi: 10.1074/jbc.M116.721597. Epub 2016 Mar 10.

引用本文的文献

1
Serum immunoglobulin and the threshold of Fc receptor-mediated immune activation.血清免疫球蛋白和 Fc 受体介导的免疫激活阈值。
Biochim Biophys Acta Gen Subj. 2023 Nov;1867(11):130448. doi: 10.1016/j.bbagen.2023.130448. Epub 2023 Aug 29.
2
Extensive substrate recognition by the streptococcal antibody-degrading enzymes IdeS and EndoS.链球菌抗体降解酶 IdeS 和 EndoS 的广泛底物识别。
Nat Commun. 2022 Dec 17;13(1):7801. doi: 10.1038/s41467-022-35340-z.
3
Structural insights into the mechanisms and specificities of IgG-active endoglycosidases.IgG 活性内切糖苷酶的作用机制和特异性的结构见解。
Glycobiology. 2020 Mar 20;30(4):268-279. doi: 10.1093/glycob/cwz042.

本文引用的文献

1
A facile synthesis of a complex type N-glycan thiazoline as an effective inhibitor against the antibody-deactivating endo-β-N-acetylglucosaminidases.一种复杂型N-聚糖噻唑啉的简便合成方法,该噻唑啉是一种有效的抗抗体失活内切-β-N-乙酰氨基葡萄糖苷酶抑制剂。
J Carbohydr Chem. 2017;36(8-9):336-346. doi: 10.1080/07328303.2017.1403616. Epub 2017 Dec 7.
2
Structural basis for the recognition of complex-type N-glycans by Endoglycosidase S.内切糖苷酶 S 识别复杂型 N-聚糖的结构基础。
Nat Commun. 2018 May 14;9(1):1874. doi: 10.1038/s41467-018-04300-x.
3
One-pot enzymatic glycan remodeling of a therapeutic monoclonal antibody by endoglycosidase S (Endo-S) from Streptococcus pyogenes.通过来自化脓性链球菌的内切糖苷酶 S(Endo-S)对治疗性单克隆抗体进行一锅酶法糖基化修饰。
Bioorg Med Chem. 2018 Apr 1;26(7):1347-1355. doi: 10.1016/j.bmc.2017.07.053. Epub 2017 Jul 29.
4
Monoclonal antibodies targeting non-small cell lung cancer stem-like cells by multipotent cancer stem cell monoclonal antibody library.通过多能癌干细胞单克隆抗体文库靶向非小细胞肺癌干细胞样细胞的单克隆抗体
Int J Oncol. 2017 Feb;50(2):587-596. doi: 10.3892/ijo.2016.3818. Epub 2016 Dec 22.
5
Efficacy and safety of an anti-CD20 monoclonal antibody (Reditux™) for the treatment of patients with moderate to severe rheumatoid arthritis following the failure of conventional synthetic disease-modifying anti-rheumatic drugs.一种抗CD20单克隆抗体(利妥昔单抗™)在传统合成抗风湿药物治疗失败后用于治疗中重度类风湿关节炎患者的疗效和安全性。
Clin Rheumatol. 2016 Aug;35(8):1931-1935. doi: 10.1007/s10067-016-3332-8. Epub 2016 Jun 22.
6
Glycosynthase Mutants of Endoglycosidase S2 Show Potent Transglycosylation Activity and Remarkably Relaxed Substrate Specificity for Antibody Glycosylation Remodeling.内切糖苷酶S2的糖基合酶突变体表现出强大的转糖基化活性以及对抗体糖基化重塑显著宽松的底物特异性。
J Biol Chem. 2016 Aug 5;291(32):16508-18. doi: 10.1074/jbc.M116.738765. Epub 2016 Jun 10.
7
Endo-F3 Glycosynthase Mutants Enable Chemoenzymatic Synthesis of Core-fucosylated Triantennary Complex Type Glycopeptides and Glycoproteins.内切-F3糖基合酶突变体实现核心岩藻糖基化三天线复合型糖肽和糖蛋白的化学酶法合成。
J Biol Chem. 2016 Apr 22;291(17):9356-70. doi: 10.1074/jbc.M116.721597. Epub 2016 Mar 10.
8
Enzymatic removal of N-glycans by PNGase F coated magnetic microparticles.用PNGase F包被的磁性微粒酶法去除N-聚糖。
Electrophoresis. 2016 May;37(10):1264-9. doi: 10.1002/elps.201500575. Epub 2016 Mar 15.
9
Optimal Synthetic Glycosylation of a Therapeutic Antibody.治疗性抗体的最佳合成糖基化
Angew Chem Int Ed Engl. 2016 Feb 12;55(7):2361-7. doi: 10.1002/anie.201508723. Epub 2016 Jan 12.
10
Evaluation of a glycoengineered monoclonal antibody via LC-MS analysis in combination with multiple enzymatic digestion.通过液相色谱-质谱联用分析结合多种酶切对一种糖基工程化单克隆抗体进行评估。
MAbs. 2016;8(2):340-6. doi: 10.1080/19420862.2015.1113361. Epub 2015 Oct 29.

化脓性链球菌内切糖苷酶新型糖基合酶突变体的产生及其在抗体糖基工程中的比较动力学分析

Generation and Comparative Kinetic Analysis of New Glycosynthase Mutants from Streptococcus pyogenes Endoglycosidases for Antibody Glycoengineering.

作者信息

Tong Xin, Li Tiezheng, Li Chao, Wang Lai-Xi

机构信息

Department of Chemistry and Biochemistry , University of Maryland , College Park , Maryland 20742 , United States.

出版信息

Biochemistry. 2018 Sep 4;57(35):5239-5246. doi: 10.1021/acs.biochem.8b00719. Epub 2018 Aug 22.

DOI:10.1021/acs.biochem.8b00719
PMID:30102520
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6202118/
Abstract

Chemoenzymatic glycan remodeling by endoglycosidase-catalyzed deglycosylation and reglycosylation is emerging as an attractive approach for producing homogeneous glycoforms of antibodies, and the success of this approach depends on the discovery of efficient endoglycosidases and their glycosynthase mutants. We report in this paper a systematic site-directed mutagenesis of an endoglycosidase from Streptococcus pyogenes (Endo-S) at the critical Asp-233 (D233) site and evaluation of the hydrolysis and transglycosylation activities of the resulting mutants. We found that in addition to the previously identified D233A and D233Q mutants of Endo-S, most of the Asp-233 mutants discovered here were also glycosynthases that demonstrated glycosylation activity using glycan oxazoline as the donor substrate with diminished hydrolytic activity. The glycosynthase activity of the resultant mutants varied significantly depending on the nature of the amino acid substituents. Among them, the D233M mutant was identified as the most efficient glycosynthase variant with the highest transglycosylation/hydrolysis ratio, which is similar to the recently reported D184M mutant of Endo-S2, another S. pyogenes endoglycosidase. Kinetic studies of the D233M and D233A mutants of Endo-S, as well as glycosynthase mutants D184M and D184A of Endo-S2, indicated that the enhanced catalytic efficacy of the Asp-to-Met mutants of both enzymes was mainly due to an increased turnover number (increased k) for the glycan oxazoline substrate and the significantly enhanced substrate affinity (as judged by the reduced K value) for the antibody acceptor.

摘要

通过内切糖苷酶催化的去糖基化和再糖基化进行化学酶促聚糖重塑,正成为一种生产抗体均一糖型的有吸引力的方法,而这种方法的成功取决于高效内切糖苷酶及其糖基合酶突变体的发现。我们在本文中报道了对化脓性链球菌内切糖苷酶(Endo-S)关键的天冬氨酸-233(D233)位点进行系统的定点诱变,并对所得突变体的水解和转糖基化活性进行评估。我们发现,除了之前鉴定的Endo-S的D233A和D233Q突变体之外,这里发现的大多数天冬氨酸-233突变体也是糖基合酶,它们以聚糖恶唑啉作为供体底物表现出糖基化活性,同时水解活性降低。所得突变体的糖基合酶活性根据氨基酸取代基的性质有显著差异。其中,D233M突变体被鉴定为最有效的糖基合酶变体,具有最高的转糖基化/水解比,这与最近报道的另一种化脓性链球菌内切糖苷酶Endo-S2的D184M突变体相似。对Endo-S的D233M和D233A突变体以及Endo-S2的糖基合酶突变体D184M和D184A的动力学研究表明,这两种酶的天冬氨酸到甲硫氨酸突变体催化效率的提高主要是由于聚糖恶唑啉底物的周转数增加(k增加)以及对抗体受体的底物亲和力显著增强(通过降低的K值判断)。